Innovation does not happen in a vacuum. Much of it is driven by companies seeking competitive advantage, market share, and profit. Films from the Future explores what happens when the drive for profit shapes the direction of technology development without adequate ethical guardrails, and how easily the interests of corporations diverge from the interests of the people their technologies affect.
Jurassic Park's John Hammond is, above all else, an entrepreneur. His dream of resurrecting dinosaurs is not driven by scientific curiosity but by the vision of the world's most spectacular theme park. The science is a means to an end, and that end is profit and spectacle. When his investors get nervous after a worker is killed, Hammond does not reconsider the wisdom of his venture. He brings in scientists to provide a stamp of approval so the park can open on schedule.
The book draws out how Hammond's business priorities systematically distort the decision-making process. Safety measures are designed to reassure investors, not to manage genuine risks. Concerns raised by scientists like Ian Malcolm are treated as obstacles to be overcome rather than signals to be heeded. The park's security systems are built to a budget, and when a disgruntled, underpaid employee decides to steal embryos, the entire edifice collapses.
The pattern is familiar: corporate incentives that reward speed to market, cost reduction, and growth, while treating safety and ethics as costs to be minimized. The book uses Hammond to illustrate how this dynamic plays out with especially dangerous consequences when the technologies involved are novel, complex, and poorly understood.
Elysium takes the critique to a systemic level. The Armadyne corporation manufactures the robots that police Earth's impoverished population and maintains the infrastructure that keeps the orbital habitat's wealthy citizens in luxury. The company profits directly from the inequality the film depicts. When Max, a factory worker, receives a lethal dose of radiation on the job, his employer's response is to get him off the premises before he becomes inconvenient.
The book acknowledges that Elysium paints with a broad brush, but argues that the underlying dynamic is real. When corporations control access to transformative technologies, their pricing, distribution, and development decisions shape who benefits and who does not. Medical technologies that could save millions of lives may never reach those who need them most if there is insufficient profit in doing so. The book asks whether market-driven innovation can ever adequately serve the public good, or whether it inevitably skews toward those with purchasing power.
Ex Machina explores a more intimate form of corporate irresponsibility. Nathan Bateman is both a technology entrepreneur and a sole proprietor of his AI research. He treats his AI creations, Ava and Kyoko, as products to be tested, used, and discarded. Kyoko serves his personal needs and is treated as something between a servant and an appliance. Ava is a test subject whose consciousness and apparent capacity for suffering are irrelevant to Nathan's assessment of her value.
The book uses Nathan to explore what happens when the power dynamics of the creator-product relationship are applied to entities that may have genuine awareness. If a company creates something that can think and feel, what obligations does it have? Current legal and ethical frameworks offer little guidance, and the default, treating AI as property, may prove deeply inadequate if and when artificial consciousness emerges.
Ghost in the Shell adds another layer by depicting a world where human augmentation is a commercial enterprise. Bodies are upgraded with proprietary technology, creating dependencies that extend corporate influence into the most personal domain imaginable. The film raises the specter of a body that is partly owned by the company that manufactured its components, a scenario that becomes less hypothetical as medical devices, implants, and wearable technologies become more sophisticated and more integrated into our biology.
The book connects this to existing debates about device right-to-repair, about who owns the data generated by implanted medical devices, and about the terms of service that increasingly govern our relationship with the technologies embedded in our lives.
Across these films, the book identifies a persistent tension between the engine of profit-driven innovation and the interests of the people that innovation is supposed to serve:
The book does not argue that profit-driven innovation is inherently wrong. It recognizes that market incentives have produced extraordinary technological advances. But it insists that markets without ethical guardrails will consistently prioritize returns over responsibility, and that the consequences of this become more severe as the technologies in question become more powerful.
For the technologies shaped by these dynamics, see Artificial Intelligence, Automation and the Future of Work, and Human Augmentation. For how power and privilege shape access, see Power, Privilege, and Access.